|
(V1672) |
Disturbed AMPK-Activation and Acrp30 signalling – impact for heart failure therapy? |
| |
|
B. Niemann, R. Pan, L. Li, H. Bugger, A. Böning, S. Rohrbach (Gießen, Freiburg im Breisgau) |
|
|
Diskussion |
|
(V1673) |
Ivabradine reduces digitalis-mediated ventricular arrhythmias |
| |
|
G. Frommeyer, J. Weller, C. Ellermann, N. Bögeholz, H. Bogossian, S. Kochhäuser, D. Dechering, C. Pott, L. Eckardt (Münster, Lüdenscheid) |
|
|
Diskussion |
|
(V1674) |
Loss of the small leucine-rich proteoglycan Biglycan worsens hemodynamic function and leads to increased mortality in angiotensin II-induced heart failure |
| |
|
P. M. Becher, D. Lindner, S. Blankenberg, D. Westermann (Hamburg) |
|
|
Diskussion |
|
(V1675) |
The H19 long non-coding RNA regulates cardiac hypertrophy through an epigenetic regulator |
| |
|
J. Viereck, A. Foinquinos, K. Xiao, J. A. Kleeberger, A. Schambach, L. Dandolo, F. Weidemann, S. Engelhardt, S. Batkai, T. Thum (Hannover, Unna, München; Paris, FR) |
|
|
Diskussion |
|
(V1676) |
Thyroid-Stimulating Hormone and Adverse Left Ventricular Remodelling Following ST-elevation Myocardial Infarction |
| |
|
M. Reindl, H.-J. Feistritzer, S. J. Reinstadler, L. Mueller, C. Tiller, C. Brenner, A. Mayr, B. Henninger, J. Mair, G. Klug, B. Metzler (Innsbruck, AT) |
|
|
Diskussion |
|
(V1677) |
GLP-1 secretion is increased in a murine model of myocardial infarction leading to improved left ventricular function and mitochondrial respiratory capacity |
| |
|
S. Diebold, J. Möllmann, F. Kahles, A. Nickel, C. Maack, N. Marx, M. Lehrke (Aachen, Homburg/Saar) |
|
|
Diskussion |